These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7723585)

  • 21. Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats.
    Schultz MK; Wright LK; de Araujo Furtado M; Stone MF; Moffett MC; Kelley NR; Bourne AR; Lumeh WZ; Schultz CR; Schwartz JE; Lumley LA
    Neurotoxicol Teratol; 2014; 44():89-104. PubMed ID: 24946037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
    Kim HC; Shin CY; Seo DO; Jhoo JH; Jhoo WK; Kim WK; Shin EJ; Lee YH; Lee PH; Ko KH
    Life Sci; 2003 Mar; 72(16):1883-95. PubMed ID: 12586225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
    Raveh L; Weissman BA; Cohen G; Alkalay D; Rabinovitz I; Sonego H; Brandeis R
    Neurotoxicology; 2002 May; 23(1):7-17. PubMed ID: 12164550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of non-opioid antitussives on hypoxia-induced electrical changes in rat hippocampal slices: a comparative study with anticonvulsant drugs.
    Domenici MR; Sagratella S; Frank C; Scotti de Carolis A
    Gen Pharmacol; 1993 Jul; 24(4):991-8. PubMed ID: 8224752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.
    Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; Pidoplichko VI; Rossetti K; Braga MFM
    J Pharmacol Exp Ther; 2018 May; 365(2):314-326. PubMed ID: 29467308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex.
    Roth JE; Franklin PH; Murray TF
    Eur J Pharmacol; 1993 May; 236(2):327-31. PubMed ID: 8319759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
    Raveh L; Chapman S; Cohen G; Alkalay D; Gilat E; Rabinovitz I; Weissman BA
    Neurotoxicology; 1999 Aug; 20(4):551-9. PubMed ID: 10499354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of some 2-substituted derivatives of xanthone for anticonvulsant properties.
    Marona H
    Pharmazie; 1998 Jun; 53(6):405-9. PubMed ID: 9675771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of PNU-151774E as a novel anticonvulsant.
    Fariello RG; McArthur RA; Bonsignori A; Cervini MA; Maj R; Marrari P; Pevarello P; Wolf HH; Woodhead JW; White HS; Varasi M; Salvati P; Post C
    J Pharmacol Exp Ther; 1998 May; 285(2):397-403. PubMed ID: 9580576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anticonvulsant activity of 1,2-aminoalkanol derivatives.
    Marona H; Antkiewicz-Michaluk L
    Acta Pol Pharm; 1998; 55(6):487-98. PubMed ID: 10073136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulation of dextromethorphan binding sites.
    Musacchio JM; Klein M; Santiago LJ
    Neuropharmacology; 1987 Jul; 26(7B):997-1001. PubMed ID: 2821439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives.
    Mawasi H; Bibi D; Bialer M
    Bioorg Med Chem; 2016 Sep; 24(18):4246-4253. PubMed ID: 27469980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam.
    Schultz MK; Wright LK; Stone MF; Schwartz JE; Kelley NR; Moffett MC; Lee RB; Lumley LA
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):376-86. PubMed ID: 22310180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.
    Palmer GC; Murray RJ; Cramer CL; Stagnitto ML; Knowles MK; Freedman LR; Eismann MS; Mahmood N; Balestra M; Borrelli AR; Hudzik TJ; McCarthy DJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):121-32. PubMed ID: 9862762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convulsant and anticonvulsant cyclopentanones and cyclohexanones.
    Holland KD; Naritoku DK; McKeon AC; Ferrendelli JA; Covey DF
    Mol Pharmacol; 1990 Jan; 37(1):98-103. PubMed ID: 2153913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Finnell RH; Wlodarczyk BJ; Yavin E; Bialer M
    Epilepsia; 2014 Dec; 55(12):1944-52. PubMed ID: 25442425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones.
    Kamiński K; Obniska J; Chlebek I; Wiklik B; Rzepka S
    Bioorg Med Chem; 2013 Nov; 21(21):6821-30. PubMed ID: 23993970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticonvulsant activity of pregabalin in the maximal electroshock-induced seizure assay in α2δ1 (R217A) and α2δ2 (R279A) mouse mutants.
    Lotarski S; Hain H; Peterson J; Galvin S; Strenkowski B; Donevan S; Offord J
    Epilepsy Res; 2014 Jul; 108(5):833-42. PubMed ID: 24698052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones--the role of primary terminal amino group.
    Pandeya SN; Mishra V; Ponnilavarasan I; Stables JP
    Pol J Pharmacol; 2000; 52(4):283-90. PubMed ID: 11345484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.